Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Novel group of compounds identified as chemokine antagonists

Jan. 28, 2002

Cellegy readying launch of Anogesic

Jan. 28, 2002

Polyheal 1 enters clinical study for treatment of foot ulcers in diabetic neuropathic patients

Jan. 28, 2002

Cell adhesion inhibitors described in patent by Tanabe Seiyaku

Jan. 25, 2002

Dermabond product labeling changed to include protection against common microbes

Jan. 23, 2002

Orally and topically administered C5a antagonist effective in dermal immunoinflammatory reaction

Jan. 18, 2002

CollaGenex expands into dermatology

Jan. 17, 2002

Synthetic selectin antagonist OJ-R9188 may be useful in Rx of atopic dermatitis

Jan. 14, 2002

Solaraze now being marketed for actinic keratosis in U.S.

Jan. 11, 2002

First patients treated in phase II trial of PhotoPoint drug MV-9411 in psoriasis

Jan. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...